G01N30/0005

One-step protein analysis using slanted nanofilter array

This disclosure provides an apparatus and a method for quickly, efficiently and continuously fractionating biomolecules, such as DNAs and proteins based on size and other factors, while allowing imaging of the separated biomolecules as they are processed within the apparatus. The apparatus employs angled nanochannels to first preconcentrate and then separate like molecules. Its embodiments offer improved detection sensitivity and separation resolution over existing technologies and multiplexing capabilities.

REGULATING A DETECTOR FLOW OF A FIELD FLOW FRACTIONATOR
20210003433 · 2021-01-07 · ·

The present disclosure describes an apparatus, method, and system of regulating a detector flow of a field flow fractionator. In an embodiment, the apparatus includes (1) a detector flow meter, where the detector flow meter is configured to measure a detector flow from the field flow fractionator, (2) a channel pressure meter, where the channel pressure meter is configured to measure a channel pressure of the field flow fractionator, (3) at least one control valve, where an inlet of the at least one control valve is connected to an outlet of the channel pressure meter, (4) where the detector flow meter is configured to set a channel pressure set point of the channel pressure meter, and (5) where the channel pressure meter is configured to actuate the at least one control valve to maintain a channel pressure of the field flow fractionator at the channel pressure set point.

REGULATING A DETECTOR FLOW OF A FIELD FLOW FRACTIONATOR
20210003433 · 2021-01-07 · ·

The present disclosure describes an apparatus, method, and system of regulating a detector flow of a field flow fractionator. In an embodiment, the apparatus includes (1) a detector flow meter, where the detector flow meter is configured to measure a detector flow from the field flow fractionator, (2) a channel pressure meter, where the channel pressure meter is configured to measure a channel pressure of the field flow fractionator, (3) at least one control valve, where an inlet of the at least one control valve is connected to an outlet of the channel pressure meter, (4) where the detector flow meter is configured to set a channel pressure set point of the channel pressure meter, and (5) where the channel pressure meter is configured to actuate the at least one control valve to maintain a channel pressure of the field flow fractionator at the channel pressure set point.

SEALING A FIELD FLOW FRACTIONATOR

The present disclosure describes a field flow fractionator (FFF). In an embodiment, the FFF includes a spacer including a core, and a coating covering the core. In an embodiment, the FFF includes a spacer including a core, and a coating covering the core, a bottom block including pins, and a top block including mating holes to receive the pins, where the spacer is configured to be positioned between the top block and the bottom block. In an embodiment, the FFF includes a spacer including a core including an opening, a top side, and a bottom side, a first coating covering the top side, and a second coating covering the bottom side, a top block configured to press on the first coating along a first periphery of the opening, and a bottom block configured to press on the second coating along a second periphery of the opening.

SYSTEM AND METHOD FOR SEPARATION OF CHIRAL COMPOUNDS USING MAGNETIC INTERACTIONS

Systems and methods are disclosed for use in the separation of chiral compounds, and enantiomers in particular. The system comprises a cavity (110) for containing a fluid mixture that comprises one or more types of chiral molecules, which may also include enantiomers, and at least one ferromagnetic or paramagnetic substrate (120) providing at least one interface (130) with said fluid mixture. The substrate (120) is magnetized providing a magnetic field Bz perpendicular to said ferromagnetic or paramagnetic interface (130), thereby providing a variation in the interaction energy of chiral molecules of different handedness, aka. enantiomers, with said substrate (120).

Device for the fractionation of objects and fractionation method
10788463 · 2020-09-29 ·

The present invention relates to a device and a method for dynamic fractionation of a dispersed phase in a fluid. The device comprises a fractionation channel and from a first to a third injection ports. A first and a second confining fluids are injectable through the first and second injection ports, respectively. An elution fluid for transporting the dispersed phase is injectable into the channel through a third injection port which is arranged between the first and second injection ports. An end portion of the channel comprises from a first to a third terminal portion respectively arranged in correspondence to the first to the third injection ports and having a geometry such that the first and second confining fluids respectively have a first and second predefined flow rate and the elution fluid have a third predefined flow rate which is larger than the first and second predefined flow rates.

SYSTEM FOR CONCENTRATION AND PRE-CONCENTRATION BY SAMPLE STACKING AND/OR PURIFICATION FOR ANALYSIS

The invention relates to a system (700) for treating molecules or particles of interest carried by a viscoelastic liquid, which comprises: a means (715) for establishing a laminar flow, during at least one portion, referred to as concentration phase, of the operating time of the system, of the viscoelastic liquid in a concentration, stacking and/or purification device (705), said device comprising a concentration area having, in the direction of said flow, an intake cross-section surface that is larger than the cross-section surface of each outlet channel, and a means (725) for applying an electric field between the intake and the outlet of the concentration area during the concentration phase, the action of the electric field on the molecules or particles of interest being, in the concentration area, opposite to the direction of said flow and causing the molecules or particles of interest to be retained at least in the concentration area;
which also comprises a modulation means (730) configured to control the means for applying the electric field in order to apply, after the concentration phase, an electric field with intensity other than zero and lower than the intensity of the electric field applied during the concentration phase.

CLEANING METHOD OF FIELD-FLOW-FRACTIONATION APPARATUS
20200249208 · 2020-08-06 ·

Provided is a field-flow-fractionation apparatus that is configured to supply a carrier fluid to a waste fluid chamber through a fluid supply flow path at a flow rate higher than a set flow rate of a flow rate adjusting part at a timing between an end of analysis of a sample and a start of analysis of a subsequent sample, thereby forming a flow of the carrier fluid from the waste fluid chamber to the separation channel. Accordingly, the sample adhering to a separation membrane is separated from the separation membrane and is discharged from the outlet port.

CENTRIFUGAL FIELD-FLOW FRACTIONATION DEVICE
20200122158 · 2020-04-23 · ·

Provided is a centrifugal field-flow fractionation device in which a liquid sample is less likely to leak from a channel and attachment and detachment work of a channel member is facilitated. By integrally forming an outer peripheral surface 162 and an inner peripheral surface 163 of a channel member 16, the channel member 16 is configured as one hollow member having a channel 161 formed inside. Thus, pressure resistance performance of the channel member 16 is improved, formation of a gap in the channel 161 can be prevented, and deterioration in sealing performance due to secular change is not generated. Accordingly, a liquid sample is less likely to leak from the channel 161. Further, since the channel member 16 can be handled as one member, attachment and detachment work of the channel member 16 is facilitated.

Methods for Characterizing Protein Complexes
20200072844 · 2020-03-05 ·

Methods for characterizing protein complexes formed between protein drug products and soluble ligands are provided herein. The disclosed methods can determine the size, heterogeneity, and conformation of protein complexes.